business
Apotex Said to Be Expected to Price IPO At Top End of Range
Apotex Health Corp. is guiding investors to expect its Toronto initial public offering to price at the top of the marketing range later Tuesday, according to people familiar with the matter.
Read full story on Bloomberg Markets → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop